Filing Flows

Filing Flows › Cosmos Health (COSM) › Q1 2026

Cosmos Health (COSM) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 20, 2026

Cosmos Health (COSM) reported revenue of $17.9M for the first quarter 2026 (Q1 2026), +31% from a year earlier and -9% from the quarter before. Operating margin was -12.2%, net loss $2.8M (15.6% of revenue).

Revenue$17.9M
Year over year+31%
Quarter over quarter-9%
Operating margin-12.2%
Net earnings−$2.8M

Cosmos Health, Q1 2026: revenue $17.9M (+31% year over year), operating margin -12.2%, net loss $2.8M, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$17.9M-9%+31%
Operating profit−$2.2M——
Net earnings−$2.8M——
Operating cash flow−$1.1M——

What changed

Revenue was $17.9M in Q1 2026, up 31% year over year and down 9% from the previous quarter. Wholesale was the largest line at 94% of revenue. Wholesale added $4.4M year over year (up 35%), 104% of the total change. Nutraceuticals and Pharmaceuticals declined 15%.

Gross margin was 7.7%, down 7.2 points from Q1 2025. Operating costs exceeded revenue by $2.2M, an operating margin of -12.2%. Operating expenses grew 24% against revenue growth of 31%. The fastest-growing cost line was Other operating costs (+28%). The quarter ended with a net loss of $2.8M, narrower than the previous quarter's $10.1M loss.

Operating cash flow was −$1.1M. Non-cash charges added back $347K of depreciation and amortization and $536K of share-based compensation. Working capital and other items added $856K. Capital expenditures of $11K exceeded it, leaving free cash flow of −$1.1M.

Questions

What was Cosmos Health's revenue in the first quarter 2026?

Cosmos Health (COSM) reported revenue of $17.9M for the first quarter 2026 (Q1 2026), +31% from a year earlier and -9% from the quarter before.

Was Cosmos Health profitable in the first quarter 2026?

Operating loss was $2.2M (-12.2% of revenue) and net loss $2.8M.

Open the interactive Sankey →

Source: Cosmos Health 10-Q on SEC EDGAR.